Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Global Stemline Therapeutics, Inc Market 2016 Share, Trend, Segmentation and Forecast to 2022

Monday, October 10, 2016 5:33
% of readers think this story is Fact. Add your two cents.

(Before It's News)


‘Stemline Therapeutics, Inc. – Product Pipeline Review – 2016’, provides an overview of the Stemline Therapeutics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Stemline Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Complete report details @

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.


- The report provides a snapshot of the pipeline therapeutic landscape of Stemline Therapeutics, Inc. 
- The report provides overview of Stemline Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Stemline Therapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Stemline Therapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Request a sample report @

Reasons to buy

- Evaluate Stemline Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline 
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Stemline Therapeutics, Inc. 
- Identify potential new clients or partners in the target demographic 
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics 
- Devise corrective measures for pipeline projects by understanding Stemline Therapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics 
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Make an enquiry before buying this Report @

Key points in table of content

Table of Contents 
Table of Contents 2 
List of Tables 5 
List of Figures 5 
Stemline Therapeutics, Inc. Snapshot 6 
Stemline Therapeutics, Inc. Overview 6 
Key Information 6 
Key Facts 6 
Stemline Therapeutics, Inc. – Research and Development Overview 7 
Key Therapeutic Areas 7 
Stemline Therapeutics, Inc. – Pipeline Review 10 
Pipeline Products by Stage of Development 10 
Pipeline Products – Monotherapy 11 
Stemline Therapeutics, Inc. – Pipeline Products Glance 12 
Stemline Therapeutics, Inc. – Clinical Stage Pipeline Products 12 
Phase II Products/Combination Treatment Modalities 12 
Phase I Products/Combination Treatment Modalities 13 
Stemline Therapeutics, Inc. – Early Stage Pipeline Products 14 
Preclinical Products/Combination Treatment Modalities 14 
Stemline Therapeutics, Inc. – Drug Profiles 15 
SL-401 15 
Product Description 15 
Mechanism of Action 15 
R&D Progress 15 
SL-701 18 
Product Description 18 
Mechanism of Action 18 
R&D Progress 18 
SL-801 20 
Product Description 20 
Mechanism of Action 20 
R&D Progress 20 
Monoclonal Antibodies to Inhibit IL-3RA for Autoimmune Disorders 22 
Product Description 22 
Mechanism of Action 22 
R&D Progress 22 
Monoclonal Antibody to Antagonize Frizzled Receptor for Oncology 23 
Product Description 23 
Mechanism of Action 23 
R&D Progress 23 
Monoclonal Antibody to Antagonize Patched for Oncology 24 
Product Description 24 
Mechanism of Action 24 
R&D Progress 24 
Monoclonal Antibody to Antagonize Tie-1 Receptor for Oncology 25 
Product Description 25 
Mechanism of Action 25 
R&D Progress 25 
Monoclonal Antibody to Inhibit CD133 for Oncology 26 
Product Description 26 
Mechanism of Action 26 
R&D Progress 26 
Monoclonal Antibody to Inhibit Glypican-3 for Oncology 27 
Product Description 27 
Mechanism of Action 27 
R&D Progress 27 
Monoclonal Antibody to Inhibit Smoothened for Oncology 28 
Product Description 28 
Mechanism of Action 28 
R&D Progress 28 
SL-101 29 
Product Description 29 
Mechanism of Action 29 
R&D Progress 29 
SL-201 30 
Product Description 30 
Mechanism of Action 30 
R&D Progress 30 
SL-202 31 
Product Description 31 
Mechanism of Action 31 
R&D Progress 31 
SL-301 32 
Product Description 32 
Mechanism of Action 32 
R&D Progress 32 
SL-302 33 
Product Description 33 
Mechanism of Action 33 
R&D Progress 33 
SL-501 34 
Product Description 34 
Mechanism of Action 34 
R&D Progress 34 
SL-601 35 
Product Description 35 
Mechanism of Action 35 
R&D Progress 35 
Stemline Therapeutics, Inc. – Pipeline Analysis 36 
Stemline Therapeutics, Inc. – Pipeline Products by Target 36 
Stemline Therapeutics, Inc. – Pipeline Products by Route of Administration 37 
Stemline Therapeutics, Inc. – Pipeline Products by Molecule Type 38 
Stemline Therapeutics, Inc. – Pipeline Products by Mechanism of Action 39 
Stemline Therapeutics, Inc. – Recent Pipeline Updates 40 
Stemline Therapeutics, Inc. – Dormant Projects 46 
Stemline Therapeutics, Inc. – Locations And Subsidiaries 47 
Head Office 47 
Appendix 48 
Methodology 48 
Coverage 48 
Secondary Research 48 
Primary Research 48 
Expert Panel Validation 48 
Contact Us 48 
Disclaimer 49

List of Tables 
Stemline Therapeutics, Inc., Key Information 6 
Stemline Therapeutics, Inc., Key Facts 6 
Stemline Therapeutics, Inc. – Pipeline by Indication, 2016 8 
Stemline Therapeutics, Inc. – Pipeline by Stage of Development, 2016 10 
Stemline Therapeutics, Inc. – Monotherapy Products in Pipeline, 2016 11 
Stemline Therapeutics, Inc. – Phase II, 2016 12 
Stemline Therapeutics, Inc. – Phase I, 2016 13 
Stemline Therapeutics, Inc. – Preclinical, 2016 14 
Stemline Therapeutics, Inc. – Pipeline by Target, 2016 36 
Stemline Therapeutics, Inc. – Pipeline by Route of Administration, 2016 37 
Stemline Therapeutics, Inc. – Pipeline by Molecule Type, 2016 38 
Stemline Therapeutics, Inc. – Pipeline Products by Mechanism of Action, 2016 39 
Stemline Therapeutics, Inc. – Recent Pipeline Updates, 2016 40 
Stemline Therapeutics, Inc. – Dormant Developmental Projects,2016 46

Get this report @

Contact US:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.